BioLineRx, a biopharmaceutical development company, announced the publication of pre-clinical results demonstrating that BL-7010, an orally available treatment for celiac disease, reduces gluten toxicity.
46740
BioLineRx announces publication of pre-clinical results
73557
Obesity drug sails through trials
80653
Chemicals shield may fight cancer
57885
Symposium on targeted cancer therapy, Heidelberg, Germany
110203
A mysterious form of cell death uncovers prime suspect for new cancer drug development
19743
Boston Scientific assigned patent for drug delivery
116050
Cetylpyridinium chloride reduces plaque, calculus
73994
GlaxoSmithKline uses clinical graphics solution developed by Insightful Corporation
95241
Common cancer drugs may offer treatment for type 1 diabetes
156830
Boston Scientific PREVAIL trial meets two out of three co-primary endpoints
108236
Abbott licenses biomarkers for use in differentiating aggressive from nonaggressive prostate cancer
49024
Human embryonic stem cells may revolutionize the treatment of oral diseases
98125
Oral drops provide a safe and effective alternative for allergy sufferers
16779
Researchers create new green method for developing medicines
58909
Researchers develop model of how errors are corrected whilst proteins are being built
1830
Pivotal study with vismodegib shows positive results in people with advanced BCC
166262
Roche now offers expanded portfolio of blood screening solutions